{
  "docId": "019de073-e60e-740c-a4d1-b8dd6fcd421d",
  "docSlug": "c76f9a1cfbf11e27618f62d901587aa3",
  "documentTitle": "Alkermes | Results Presentation Deck | 22 slides",
  "authorId": "alkermes",
  "authorName": "Alkermes",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 7,
  "pageCount": 22,
  "prevPage": 6,
  "nextPage": 8,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "overcrowded",
  "nDataPoints": 0,
  "notes": "The slide outlines the value proposition of a spin-off scenario.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-e60e-740c-a4d1-b8dd6fcd421d/7",
  "deckHref": "/decks/019de073-e60e-740c-a4d1-b8dd6fcd421d",
  "deckJsonHref": "/decks/019de073-e60e-740c-a4d1-b8dd6fcd421d.json",
  "deckAnchorHref": "/decks/019de073-e60e-740c-a4d1-b8dd6fcd421d#slide-7",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.9,
        "x": 0.05,
        "y": 0.21
      },
      "kind": "callout",
      "text": "Builds on Alkermes heritage of innovation and excellence in neuroscience",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "137173a8-28ea-42af-9897-e09f7dea05c0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.9,
        "x": 0.05,
        "y": 0.81
      },
      "kind": "callout",
      "text": "Separation expected to enhance profitability",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4e7ea4e0-54c7-421b-8167-f79983520588",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.28,
        "x": 0.36,
        "y": 0.45
      },
      "kind": "list",
      "text": "Commercial Capabilities: Established commercial capabilities in psychiatry and addiction; Opportunity to capture operating leverage",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "aabeb465-b7d8-4e40-92fe-0d53292a16dc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.28,
        "x": 0.06,
        "y": 0.45
      },
      "kind": "list",
      "text": "Proprietary Products: Topline primarily driven by growth of proprietary commercial products in addiction and psychiatry",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d2a80589-8549-4a26-a31f-1f76f9f776a1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.28,
        "x": 0.66,
        "y": 0.45
      },
      "kind": "list",
      "text": "Development Pipeline: Early-stage neuroscience pipeline: ALKS 2680, orexin 2 receptor agonist in phase 1; Portfolio of preclinical neuroscience assets",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e407bb6b-36ba-4c7f-8323-7925804b056b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.6,
        "x": 0.05,
        "y": 0.9
      },
      "kind": "source-note",
      "text": "Assuming separation is effected through a spin-off of the oncology business into an independent, publicly-traded company",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a831cbd2-4731-4814-a609-59a925f8b44b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.8,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Post-Separation Alkermes: Pure-Play, Commercial-Stage Neuroscience Company",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c74fe8de-af89-4a4f-8621-1450cbc34213",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 9,
      "from": 6,
      "beatId": "447f6264-8955-4168-914e-cfe1363597e7",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Satisfaction",
      "beatSlug": "monroes-sequence-satisfaction",
      "evidence": "The document proposes a solution (separation of oncology business) and presents expected outcomes to satisfy the audience's needs.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [
    {
      "to": 9,
      "from": 6,
      "name": "Pattern Hunter",
      "slug": "02-pattern-hunter",
      "bestFor": "Time-pressed audiences, building consensus, when data is strong",
      "matchId": "a5a157cc-9029-478a-92e9-6838ab291f2a",
      "evidence": "The document presents a clear pattern of benefits, including enhanced profitability and clear value propositions.",
      "position": 0,
      "objective": "What are the benefits of separating the oncology business?",
      "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion",
      "confidence": 0.7,
      "description": "Group multiple pieces of evidence that together point to a pattern or conclusion"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}